An observational study in SCAD, Addison Disease and Ankylosing Spondylitis, sponsored by Mayo Clinic. Completed at 1 site in United States. Open to participants aged 18 Years to 110 Years. Per ClinicalTrials.gov, last updated 2020-11-23.
Sponsored by Mayo Clinic · Observational
This case control study aims to determine whether spontaneous coronary artery dissection (SCAD) is associated with autoimmune diseases and to update the incidence of SCAD in a population-based cohort.
36 studies on the registry are indexed under Addison Disease; 9 are open to participants now.
This study's enrollment of 114 is above the median of 91 across 10 observational studies indexed under Addison Disease.
Browse Addison Disease studies →Mayo Clinic is the lead sponsor of 3,269 studies on the registry; 672 are open to participants now.
Of its 452 completed or terminated interventional studies of FDA-regulated products, 321 (71%) have results posted.
Counted across the registry records on this site, refreshed daily.
The Rochester Epidemiology Project (REP) is a population-based cohort that includes medical record data for over 500,000 unique individuals who resided in Olmsted County at some point between 1966 and the present, and received health care for any reason within the system (St. Sauver 2012).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
SCAD cases will be identified based on presence of at least one diagnosis code for SCAD followed by manual verification by a trained individual, OR, inclusion in the previously validated SCAD cohort (Tweet 2012).
Potential controls will be identified based on absence of any SCAD diagnosis codes.
Odds of autoimmune disease in SCAD cases compared to controls
Time frame: Through study completion, or approximately 50 years (average age of study participants)
Incidence Rate of SCAD
Time frame: Through study completion, or approximately 50 years (average age of study participants)
SCAD recurrence
Time frame: Through study completion, or approximately 50 years (average age of study participants)
Odds of laboratory markers for autoimmune disease in SCAD cases compared to controls
Time frame: Through study completion, or approximately 50 years (average age of study participants)
Odds of validated rheumatoid arthritis in SCAD cases compared to controls
using the Rochester Epidemiology Project Rheumatoid Arthritis cohort
Time frame: Through study completion, or approximately 50 years (average age of study participants)
Plan to share: No
Ran from Jan 1995 to primary completion in Nov 2020, 310 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.